ConductScience.org, home

Library / Trial comparisons

Polypharmacy vs No Polypharmacy: Complications

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.2160.2140.218wilsonClinicalTrials.gov
Risk in group 20.1640.1620.167wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.05170.04870.0547newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 21.311.291.34logClinicalTrials.gov
Odds ratio, group 1 over group 21.41.371.43logClinicalTrials.gov
Number needed to treat, for one more participant with the outcome on Polypharmacy than on No Polypharmacy19.318.320.5from the risk difference intervalClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1PolypharmacyPeople taking \>=5 unique prescription drugs in the 3 months prior to surgery~Polypharmacy: Patients who are taking \>=5 unique prescription drugs in the 3 months prior to surgery31,570146,029OG000ClinicalTrials.gov
Group 2No PolypharmacyPeople taking \<5 unique prescription drugs in the 3 months prior to surgery19,815120,470OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleComplicationsClinicalTrials.gov
DescriptionPatient with a complication based on clusters of ICD-10 Type 2 codes collected in the hospital recordClinicalTrials.gov
Time frameFrom day of surgery to day of hospital discharge, up to 365 days after surgeryClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitlePolypharmacy and Outcomes After Elective Noncardiac SurgeryClinicalTrials.gov
NCT numberNCT03133182ClinicalTrials.gov
PhasesClinicalTrials.gov
ConditionsPolypharmacy, Surgical Procedure, Operative, Morality, EpidemiologyClinicalTrials.gov
InterventionsPolypharmacyClinicalTrials.gov
Lead sponsorOttawa Hospital Research InstituteClinicalTrials.gov
Results first posted2025-01-24ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT03133182?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.